Librela for dogs | Zoetis Pets

Alleviate your dog's arthritis pain – for improved quality of life

If your dog is in pain from arthritis, Librela provides proven, effective pain relief, so that they can have more days of play. No need to give a daily oral medication, Librela is a monthly injection administered by your vet. It starts working fast^*, providing month-long pain relief and improved mobility.

Use Left and Right Arrow keys to navigate between slides.

Month-long arthritis pain relief¹

Helps to improve your dog’s comfort and mobility¹

An effective alternative to daily oral pain relief¹

Can reduce the need for other medications to manage OA pain²

No known interactions with other medications¹

Librela is an innovative protein-based therapy (monoclonal antibody). It works like your dog's own immune system, targeting a protein that causes arthritis pain.
Librela is given by your vet as a simple monthly injection – removing the sometimes challenging need to give your dog oral treatments every day.
From the first treatment with Librela, dogs experience reduced pain – for an improved quality of life with each monthly injection.
Tested in clinical studies, Librela was found to be well tolerated, allowing more dogs with arthritis pain to experience long-term pain relief.²
No requirement for costly bloodwork at regular intervals.

70+

Years for Zoetis as the global leader in animal health

1 month

Librela injection alleviates arthritis pain for 1 whole month¹

96%

Of vets would choose Librela for their own dog⁴

References

^*Onset of efficacy seen at 7 days post administration¹

1.Librela GB SPC

2. Gildea, E., North, C., Walker, K., Adriaens, F., & Lascelles, B. D. X. (2024). Use of Bedinvetmab (Librela^®) for Canine Osteoarthritis in France, Germany, Italy, Spain, and the UK: Quantitative Analysis of Veterinarian Satisfaction and Real-World Treatment Patterns. Animals: an open access journal from MDPI, 14(15), 2231. https://doi.org/10.3390/ani14152231

3. Global pharmacovigilance shipment data on file accessed through SAP/DataMart. June 2025.

4. Kynetec Aug 2024, 96% of vets (n=150) would use Librela on their own dog if it was diagnosed with OA.